In the wake of unequal vaccine rollouts, countries face a ‘Wild West’ scramble for covid pills

Advertisements

The generic versions of the drug would not only aid manufacturing, but they would probably be cheaper. In early deals made with the United States, Merck sold molnupiravir for $712 a treatment course, Pfizer sold Paxlovid for $530. Brook Baker, a professor of law at Northeastern University who tracks pharmaceutical deals, estimates generics of molnupiravir could be sold for as little as $10 per treatment.

The Washington Post: Breaking News, World, US, DC News and Analysis